Загрузка...
Sodium-Glucose Cotransporter-2 Inhibitors in Nephrology Practice: A Narrative Review
PURPOSE OF THE REVIEW: Sodium-glucose cotransporter-2 inhibitors (SGLT2is) are recommended for eligible patients with type 2 diabetes for the secondary prevention of adverse cardiovascular and kidney disease outcomes. Patients with type 2 diabetes and albuminuric chronic kidney disease, a history of...
Сохранить в:
| Опубликовано в: : | Can J Kidney Health Dis |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7315675/ https://ncbi.nlm.nih.gov/pubmed/32637144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2054358120935701 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|